158 related articles for article (PubMed ID: 34251719)
1. Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: Identifying relevant outcome factors.
Lambert N; El Moussaoui M; Maquet P
Eur J Neurol; 2021 Nov; 28(11):3814-3819. PubMed ID: 34251719
[TBL] [Abstract][Full Text] [Related]
2. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
[TBL] [Abstract][Full Text] [Related]
3. Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: A case report with literature review.
Lan TY; Chen YS; Cheng CF; Huang ST; Shen CY; Hsu PN
Lupus; 2021 Oct; 30(11):1849-1855. PubMed ID: 34325541
[TBL] [Abstract][Full Text] [Related]
4. Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?
Roos-Weil D; Weiss N; Guihot A; Uzunov M; Bellanger A; Eymard B; Saadoun D; Houillier C; Idbaih A; Demeret S; Deback C; Leblond V; Galanaud D; Shor N; Pourcher V
J Neurol; 2021 Jul; 268(7):2458-2465. PubMed ID: 33515299
[TBL] [Abstract][Full Text] [Related]
5. Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors.
Boumaza X; Bonneau B; Roos-Weil D; Pinnetti C; Rauer S; Nitsch L; Del Bello A; Jelcic I; Sühs KW; Gasnault J; Goreci Y; Grauer O; Gnanapavan S; Wicklein R; Lambert N; Perpoint T; Beudel M; Clifford D; Sommet A; Cortese I; Martin-Blondel G;
Ann Neurol; 2023 Feb; 93(2):257-270. PubMed ID: 36151879
[TBL] [Abstract][Full Text] [Related]
6. Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.
Wijburg MT; Kleerekooper I; Lissenberg-Witte BI; de Vos M; Warnke C; Uitdehaag BMJ; Barkhof F; Killestein J; Wattjes MP
JAMA Neurol; 2018 Jul; 75(7):827-833. PubMed ID: 29532061
[TBL] [Abstract][Full Text] [Related]
7. Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathy.
Beck ES; Cortese I
Curr Opin Virol; 2020 Feb; 40():19-27. PubMed ID: 32279025
[TBL] [Abstract][Full Text] [Related]
8. Progressive multifocal leukoencephalopathy secondary to idiopathic CD4 lymphocytopenia treated with pembrolizumab.
Varmpompiti K; Westwood AJ; Ben-Joseph A; Sibtain N; Ibrahim MAA; Stanton B; Zuckerman M; Hadden R; Ritter LM
J Neuroimmunol; 2023 Dec; 385():578248. PubMed ID: 37995595
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Immune Checkpoint Inhibitors in Transplant Recipients with Progressive Multifocal Leukoencephalopathy.
Medrano C; Vergez F; Mengelle C; Faguer S; Kamar N; Del Bello A
Emerg Infect Dis; 2019 Nov; 25(11):2145-2147. PubMed ID: 31625858
[TBL] [Abstract][Full Text] [Related]
10. HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity.
Iannetta M; Bellizzi A; Lo Menzo S; Anzivino E; D'Abramo A; Oliva A; D'Agostino C; d'Ettorre G; Pietropaolo V; Vullo V; Ciardi MR
J Neurovirol; 2013 Jun; 19(3):274-9. PubMed ID: 23715894
[TBL] [Abstract][Full Text] [Related]
11. Progressive multifocal leukoencephalopathy treated with nivolumab.
Hoang E; Bartlett NL; Goyal MS; Schmidt RE; Clifford DB
J Neurovirol; 2019 Apr; 25(2):284-287. PubMed ID: 30864100
[TBL] [Abstract][Full Text] [Related]
12. Killing Two Birds With One Stone: Effective Control of Both Non-Small Cell Lung Cancer and Progressive Multifocal Leukoencephalopathy With Atezolizumab, A Case Report.
Lambert N; El Moussaoui M; Ritacco C; Moïse M; Paulus A; Delvenne P; Baron F; Sadzot B; Maquet P
Front Immunol; 2022; 13():889148. PubMed ID: 35592313
[TBL] [Abstract][Full Text] [Related]
13. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
Ishii K; Yamamoto F; Homma S; Okada Y; Nakamichi K; Saijo M; Tamaoka A
BMC Neurol; 2019 Oct; 19(1):263. PubMed ID: 31672142
[TBL] [Abstract][Full Text] [Related]
14. Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Volk T; Warnatz K; Marks R; Urbach H; Schluh G; Strohmeier V; Rojas-Restrepo J; Grimbacher B; Rauer S
J Neurol; 2022 Feb; 269(2):973-981. PubMed ID: 34196768
[TBL] [Abstract][Full Text] [Related]
15. Progressive multifocal leukoencephalopathy, advanced ductal breast carcinoma, systemic sclerosis, and checkpoint inhibitors: a therapeutic dilemma.
Baena-Álvarez B; Rodríguez-Jorge F; Beltrán-Corbellini Á; Cortés-Salgado A; De la Puente C; Corral Í
J Neurovirol; 2023 Feb; 29(1):116-119. PubMed ID: 36348234
[TBL] [Abstract][Full Text] [Related]
16. [Idiopathic CD4-positive lymphocytopenia-associated progressive multifocal leukoencephalopathy confirmed by brain biopsy following negative results of repeated CSF-JC-virus tests: a case report].
Kano Y; Inoue H; Sakurai K; Yoshida M; Miura Y; Nakamichi K; Saijo M; Yuasa H
Rinsho Shinkeigaku; 2018 Dec; 58(12):750-755. PubMed ID: 30487366
[TBL] [Abstract][Full Text] [Related]
17. [A case of progressive multifocal leukoencephalopathy presenting white matter MRI lesions extending over the cerebral cortex and a marked decrease in cerebral blood flow on SPECT, and associated with HTLV-I infection].
Takase K; Ohyagi Y; Furuya H; Nagashima K; Taniwaki T; Kira J
Rinsho Shinkeigaku; 2005 Jun; 45(6):426-30. PubMed ID: 16022467
[TBL] [Abstract][Full Text] [Related]
18. [Acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy treated with highly active anti-retroviral therapy].
Shimizu Y; Ota K; Takeuchi M; Iwata M; Yogo Y
Rinsho Shinkeigaku; 2000 Aug; 40(8):821-6. PubMed ID: 11218704
[TBL] [Abstract][Full Text] [Related]
19. Treatment options for AIDS patients with progressive multifocal leukoencephalopathy.
Hernández B; Dronda F; Moreno S
Expert Opin Pharmacother; 2009 Feb; 10(3):403-16. PubMed ID: 19191678
[TBL] [Abstract][Full Text] [Related]
20. A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes.
Clifford DB; Nath A; Cinque P; Brew BJ; Zivadinov R; Gorelik L; Zhao Z; Duda P
J Neurovirol; 2013 Aug; 19(4):351-8. PubMed ID: 23733308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]